<unk>  is a vaccine designed to treat patients with multiple sclerosis. Developed by Immune Response BioPharma, Inc. it is currently in phase II clinical trials.<unk>  is designed to stimulate FOXP3+ regulatory T-cells that can then suppress the autoreactive T-cells in some patients.
Neurovax
NeuVax
Lipotuck
OpenNeuro
BrainGate
MedFlight
TennCare
Fraxel